- Paltusotine planned to advance to a pivotal Phase 3 trial in acromegaly in H1 2021 -

View post:
Crinetics Pharmaceuticals to Review 2020 Accomplishments and Provide 2021 Plans at 39th Annual J.P. Morgan Healthcare Conference 

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh